drugset / Trial / NCT05686720
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer
Phase 0
Unknown
12 enrolled
First Affiliated Hospital of Shantou University Medical College
Guangdong ProCapZoom Biosciences Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to observe and investigate the clinical safety and efficacy of SZ011 in the treatment of advanced triple-negative breast cancer.
Timeline
- Start
- 2023-02-01
- Primary completion
- 2024-02-01
- Completion
- 2024-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SZ011 | Cell therapy | 5e+06 cells | Other |
| Subject | SZ011 | Cell therapy | 5e+07 cells | Other |
| Subject | SZ011 | Cell therapy | 2e+08 cells | Other |